MBB Public Markets’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History

MBB Public Markets’s Portfolio PRDS Stock Details PRDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-39,400	Closed	-$71.3K	–	151
2023 Q2	$71.3K	Sell	39,400 -99,150	-72%	-$181K	﹤0.01%	127
2023 Q1	$183K	Buy	138,550 +108,550	+362%	+$177K	0.01%	96
2022 Q4	$50.7K	Buy	+30,000	New	+$38K	﹤0.01%	104

Other funds holding PRDS

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

MBB Public Markets's PRDS Position: Q3 2023 in Review

MBB Public Markets sold out of Pardes Biosciences, Inc. Common Stock (PRDS) in Q3 2023, closing a stake of 39,400 shares — an estimated $71.3K sold.

MBB Public Markets first reported a position in PRDS in Q4 2022 and held it in 3 quarters. The position peaked at $183K in Q1 2023. 1 fund tracked by Wall St. Rank holds PRDS as of Q3 2023.

MBB Public Markets reported no remaining Pardes Biosciences, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
MBB Public Markets sold 39,400 Pardes Biosciences, Inc. Common Stock shares in Q3 2023, an estimated $71.3K.
MBB Public Markets first reported a position in Pardes Biosciences, Inc. Common Stock in Q4 2022 and held it in 3 quarters.
MBB Public Markets's Pardes Biosciences, Inc. Common Stock position peaked at $183K in Q1 2023.
1 fund tracked by Wall St. Rank held Pardes Biosciences, Inc. Common Stock as of Q3 2023.

Based on MBB Public Markets's 13F filing for Q3 2023, filed 14 Nov 2023.